The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors

Annual Review of Biophysics and Biomolecular Structure

Volumn 32, Issue , 2003, Pages 375-397

  Filipek, Slawomir ^a,c   Teller, David C ^a,b   Palczewski, Krzysztof ^a,b   Stenkamp, Ronald ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

Homology models; Phototransduction; Signal transduction; Transmembrane protein; Vision

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; RHODOPSIN;

BINDING SITE; CHROMATOPHORE; CRYOELECTRON MICROSCOPY; HUMAN; MOLECULAR MODEL; NONHUMAN; PHOTOTRANSDUCTION; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; RETINA ROD; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; VISION; X RAY CRYSTALLOGRAPHY;

AMINO ACID MOTIFS; CRYOELECTRON MICROSCOPY; CRYSTALLOGRAPHY; CRYSTALLOGRAPHY, X-RAY; GTP-BINDING PROTEINS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RHODOPSIN;

EID: 0037494099     PISSN: 10568700     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.biophys.32.110601.142520     Document Type: Review

References (126)

1. Albert AD, Watts A, Spooner P, Groebner G, Young J, Yeagle PL. 1997. A distance measurement between specific sites on the cytoplasmic surface of bovine rhodopsin in rod outer segment disk membranes. Biochim. Biophys. Acta 1328:74-82
2. Altenbach C, Cai KW, Klein-Seetharaman J, Khorana HG, Hubbell WL. 2001. Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 65 in helix TM1 and residues in the sequence 306-319 at the cytoplasmic end of helix TM7 and in helix HS. Biochemistry 40:15483-92
3. Altenbach C, Klein-Seetharaman J, Cai KW, Khorana HG, Hubbell WL. 2001. Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1. Biochemistry 40:15493-500
4. Ascoli M, Fanelli F, Segaloff DL. 2002. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 23:141-74
5. Baldwin JM, Schertler GFX, Unger VM. 1997. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J. Mol. Biol. 272:144-64
6. Ballesteros J, Palczewski K. 2001. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. Curr. Opin. Drug Discov. Dev. 4:561-74
7. Ballesteros JA, Jensen AD, Liapakis G, Rasmussen SGF, Shi L, et al. 2001. Activation of the beta(2)-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276:29171-77
8. Ballesteros JA, Shi L, Javitch JA. 2001. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60:1-19
9. Ballesteros JA, Weinstein H. 1995. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein coupled receptors. Methods Neurosci. 25:366-428
10. Baraldi PG, Cacciari B, Moro S, Romagnoli R, Ji XD, et al. 2001. Fluorosulfonyl-and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo 4,3-e1, 2,4-triazolo 1,5-c pyrimidine derivatives: irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies. J. Med. Chem. 44:2735-42
11. Baraldi PG, Cacciari B, Moro S, Spalluto G, Pastorin G, et al. 2002. Synthesis, biological activity, and molecular modeling investigation of new pyrazolo 4,3-e-1,2,4-triazolo 1,5-c pyrimidine derivatives as human A(3) adenosine receptor antagonists. J. Med. Chem. 45:770-80
12. Barlow DJ, Thornton JM. 1988. Helix geometry in proteins. J. Mol. Biol. 201:601-19
13. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-42
14. Birdsall NJM, Lazareno S, Popham A, Saldanha J. 2001. Multiple allosteric sites on muscarinic receptors. Life Sci. 68:2517-24
15. Bockaert J, Claeysen S, Becamel C, Pinloche S, Dumuis A. 2002. G protein-coupled receptors: dominant, players in cell-cell communication. Int. Rev. Cytol. 212:63-132
16. Borhan B, Souto ML, Imai H, Shichida Y, Nakanishi K. 2000. Movement of retinal along the visual transduction path. Science 288:2209-12
17. Buss V, Kolster K, Terstegen F, Vahrenhorst R. 1998. Absolute sense of twist of the C12-C13 bond of the retinal chromophore in rhodopsin - semiempirical and nonempirical calculations of chiroptical data. Angew. Chem. Int. Ed. 37:1893-95
18. Cai KW, Klein-Seetharaman J, Altenbach C, Hubbell WL, Khorana HG. 2001. Probing the dark state tertiary structure in the cytoplasmic domain of rhodopsin: proximities between amino acids deduced from spontaneous disulfide bond formation between cysteine pairs engineered in cytoplasmic loops 1, 3, and 4. Biochemistry 40:12479-85
19. Chaturvedi K, Christoffers KH, Singh K, Howells RD. 2000. Structure and regulation of opioid receptors. Biopolymers 55:334-46
20. Chopra A, Yeagle PL, Alderfer JA, Albert AD. 2000. Solution structure of the sixth transmembrane helix of the G-protein-coupled receptor, rhodopsin. Biochim. Biophys. Acta 1463:1-5
21. Chung DA, Zuiderweg ERP, Fowler CB, Soyer OS, Mosberg HI, Neubig RR. 2002. NMR structure of the second intracellular loop of the alpha 2A adrenergic receptor: evidence for a novel cytoplasmic helix. Biochemistry 41:3596-604
22. Dawson ES, Wells JN. 2001. Determination of amino acid residues that are accessible from the ligand binding crevice in the seventh transmembrane-spanning region of the human A(1) adenosine receptor. Mol. Pharmacol. 59:1187-95
23. Dean MK, Higgs C, Smith RE, Bywater RP, Snell CR, et al. 2001. Dimerization of G-protein-coupled receptors. J. Med. Chem. 44:4595-614
24. Ding XQ, Miller LJ. 2001. Characterization of the type A cholecystokinin receptor hormone-binding domain: use of contrasting and complementary methodologies. Peptides 22:1223-28
25. Ding XQ, Pinon DI, Furse KE, Lybrand TP, Miller LJ. 2002. Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor. Mol. Pharmacol. 61:1041-52
26. Edman K, Nollert P, Royant A, Belrhali H, Pebay-Peyroula E, et al. 1999. High-resolution X-ray structure of an early intermediate in the bacteriorhodopsin photocycle. Nature 401:822-26
27. Eilers M, Ying WW, Reeves PJ, Khorana HG, Smith SO. 2002. Magic angle spinning nuclear magnetic resonance of isotopically labeled rhodopsin. Methods Enzymol. 343:212-22
28. Erlenbach I, Kostenis E, Schmidt C, Serradeil-Le Gal C, Raufaste D, et al. 2001. Single amino acid substitutions and deletions that alter the G protein coupling properties of the V2 vasopressin receptor identified in yeast by receptor random mutagenesis. J. Biol. Chem. 276:29382-92
29. Escrieut C, Gigoux V, Archer E, Verrier S, Maigret B, et al. 2002. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor - evidence for a crucial role of Met-121 in the activation process. J. Biol. Chem. 277:7546-55
30. Fain GL, Matthews HR, Cornwall MC. 1996. Dark adaptation in vertebrate photoreceptors. Trends Neurosci. 19:502-7
31. Fanelli F, Themmen APN, Puett D. 2001. Lutropin receptor function: insights from natural, engineered, and computer-simulated mutations. IUBMB Life 51:149-55
32. Filipek S, Stenkamp RE, Teller DC, Palczewski K. 2003. G-protein-coupled receptor rhodopsin: a prospectus. Annu. Rev. Physiol. 65:851-79
33. Gerber BO, Meng EC, Dotsch V, Baranski TJ, Bourne HR. 2001. An activation switch in the ligand binding pocket of the C5a receptor. J. Biol. Chem. 276:3394-400
34. Gerlach LO, Skerlj RT, Bridger GJ, Schwartz TW. 2001. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J. Biol. Chem. 276:14153-60
35. Gershengorn MC, Osman R. 2001. Minireview: insights into G protein-coupled receptor function using molecular models. Endocrinology 142:2-10
36. Gether U, Kobilka BK. 1998. G protein-coupled receptors. II. Mechanism of agonist activation. J. Biol. Chem. 273:17979-82
37. Giragossian C, Mierke DF. 2002. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor. Biochemistry 41:4560-66
38. Gouldson PR, Dean MK, Snell CR, By-water RP, Gkoutos G, Reynolds CA. 2001. Lipid-facing correlated mutations and dimerization in G-protein coupled receptors. Protein Eng. 14:759-67
39. Govaerts C, Blanpain C, Deupi X, Ballet S, Ballesteros JA, et al. 2001. The TXP motif in the second transmembrane helix of CCR5 - a structural determinant of chemokine-induced activation. J. Biol. Chem. 276:13217-25
40. Govaerts C, Lefort A, Costagliola S, Wodak SJ, Ballesteros JA, et al. 2001. A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. J. Biol. Chem. 276:22991-99
41. Greasley PJ, Fanelli F, Rossier O, Abuin L, Cotecchia S. 2002. Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol. Pharmacol. 61:1025-32
42. Greasley PJ, Fanelli F, Scheer A, Abuin L, Nenniger-Tosato M, et al. 2001. Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J. Biol. Chem. 276:46485-94
43. Hamm HE. 2001. How activated receptors couple to G proteins. Proc. Natl. Acad. Sci. USA 98:4819-21
44. Hargrave PA, McDowell JH. 1992. Rhodopsin and phototransduction - a model system for G-protein-linked receptors. FASEB J. 6:2323-31
45. Haskell-Luevano C, Cone RD, Monck EK, Wan YP. 2001. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 40:6164-79
46. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH. 1990. Model for the structure of bacteriorhodopsin based on high-resolution electron cryomicroscopy. J. Mol. Biol. 213:899-929
47. Herzyk P, Hubbard RE. 1998. Combined biophysical and biochemical information confirms arrangement of transmembrane helices visible from the three-dimensional map of frog rhodopsin. J. Mol. Biol. 281:741-54
48. Ho HH, Ganeshalingam N, Rosenhouse-Dantsker A, Osman R, Gershengorn MC. 2001. Charged residues at the intracellular boundary of transmembrane helices 2 and 3 independently affect constitutive activity of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J. Biol. Chem. 276:1376-82
49. Horn F, Vriend G, Cohen FE. 2001. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res. 29:346-49
50. Hovelmann S, Hoffmann SH, Kuhne R, ter Laak T, Reilander H, Beckers T. 2002. Impact of aromatic residues within transmembrane helix 6 of the human gonadotropin-releasing hormone receptor upon agonist and antagonist binding. Biochemistry 41:1129-36
51. Huang P, Li J, Chen CG, Visiers I, Weinstein H, Liu-Chen LY. 2001. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: Constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. Biochemistry 40:13501-9
52. Jacobson KA, Gao ZG, Chen AS, Barak D, Kim SA, et al. 2001. Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. J. Med. Chem. 44:4125-36
53. Javitch JA, Shi L, Liapakis G. 2002. Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors. Methods Enzymol. 343:137-56
54. Ji T-H, Grossmann M, Ji I. 1998. G Protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273:17299-302
55. Kelley MT, Burckstummer T, Wenzel-Seifert K, Dove S, Buschauer A, Seifert R. 2001. Distinct interaction of human and guinea pig histamine H-2-receptor with guanidine-type agonists. Mol. Pharmacol. 60:1210-25
56. Kim HS, Barak D, Harden TK, Boyer JL, Jacobson KA. 2001. Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y(1) receptor: structure-activity relationships and receptor docking. J. Med. Chem. 44:3092-108
57. Klein-Seetharaman J, Hwa J, Cai KW, Altenbach C, Hubbell WL, Khorana HG. 2001. Probing the dark state tertiary structure in the cytoplasmic domain of rhodopsin: proximities between amino acids deduced from spontaneous disulfide bond formation between Cys316 and engineered cysteines in cytoplasmic loop 1. Biochemistry 40:12472-78
58. Knudsen SM, Tams JW, Fahrenkrug J. 2001. Functional roles of conserved transmembrane prolines in the human VPAC-(1) receptor. FEBS Lett. 503:126-30
59. Kochendoerfer GG, Lin SW, Sakmar TP, Mathies RA. 1999. How color visual pigments are tuned. Trends Biochem. Sci. 24:300-5
60. Koradi R, Billeter M, Wüthrich K. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:51-55
61. Lefkowitz RJ. 1998. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273:18677-80
62. Li J, Huang P, Chen CG, de Riel JK, Weinstein H, Liu-Chen LY. 2001. Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression. Biochemistry 40:12039-50
63. Lopez-Rodriguez ML, Benhamu B, Viso A, Murcia M, Pardo L. 2001. Study of the bioactive conformation of novel 5-HT4 receptor ligands: influence of an intramolecular hydrogen bond. Tetrahedron 57:6745-49
64. Lopez-Rodriguez ML, Murcia M, Benhamu B, Viso A, Campillo M, Pardo L. 2001. 3-D-QSAR/CoMFA and recognition models of benzimidazole derivatives at the 5-HT4 receptor. Bioorg. Med. Chem. Lett. 11:2807-11
65. Luecke H, Richter HT, Lanyi JK. 1998. Proton transfer pathways in bacteriorhodopsin at 2.3 Å resolution. Science 280:1934-37
66. Luecke H, Schobert B, Richter HT, Cartailler JP, Lanyi JK. 1999. Structure of bacteriorhodopsin at 1.55 Å resolution. J. Mol. Biol. 291:899-911
67. Macarthur MW, Thornton JM. 1991. Influence of proline residues on protein conformation. J. Mol. Biol. 218:397-412
68. Marie J, Richard E, Pruneau D, Paquet JL, Siatka C, et al. 2001. Control of conformational equilibria in the human B-2 bradykinin receptor - modeling of non-peptidic ligand action and comparison to the rhodopsin structure. J. Biol. Chem. 276:41100-11
69. Marshall GR. 2001. Peptide interactions with G-protein coupled receptors. Biopolymers 60:246-77
70. Mathies RA, Lugtenburg J. 2000. The primary photoreaction of rhodopsin. Handb. Biol. Phys. 3:55-90
71. Meng EC, Bourne HR. 2001. Receptor activation: What does the rhodopsin structure tell us? Trends Pharmacol. Sci. 22:587-93
72. Menon S, Han M, Sakmar TP. 2001. Rhodopsin: structural basis of molecular physiology. Physiol. Rev. 81:1659-88
73. Mills JS, Miettinen HM, Cummings D, Jesaitis AJ. 2000. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu. J. Biol. Chem. 275:39012-17
74. Monticelli L, Mammi S, Mierke DF. 2002. Molecular characterization of a ligand-tethered parathyroid hormone receptor. Biophys. Chem. 95:165-72
75. Neve KA, Cumbay MG, Thompson KR, Yang R, Buck DC, et al. 2001. Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D-2 receptor. Mol. Pharmacol. 60:373-81
76. Nikiforovich GV, Galaktionov S, Balodis J, Marshall GR. 2001. Novel approach to computer modeling of seven-helical transmembrane proteins: current progress in the test case of bacteriorhodopsin. Acta Biochim. Pol. 48:53-64
77. Nikiforovich GV, Marshall GR. 2001. 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenssis data. Biochem. Biophys. Res. Commun. 286:1204-11
78. Okada T, Ernst OP, Palczewski K, Hofmann KP. 2001. Activation of rhodopsin: new insights from structural and biochemical studies. Trends Biochem. Sci. 26:318-24
79. Okada T, Fujiyoshi Y, Silow M, Navarro J, Landau EM, Shichida Y. 2002. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc. Natl. Acad. Sci. USA 99:5982-87
80. Okada T, Le Trong I, Fox BA, Behnke CA, Stenkamp RE, Palczewski K. 2000. X-ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. J. Struct. Biol. 130:73-80
81. Okada T, Palczewski K. 2001. Crystal structure of rhodopsin: implications for vision and beyond. Curr. Opin. Struct. Biol. 11:420-26
82. Okada T, Takeda K, Kouyama T. 1998. Highly selective separation of rhodopsin from bovine rod outer segment membranes using combination of divalent cation and alkyl(thio)glucoside. Photochem. Photobiol. 67:495-99
83. Oksche A, Leder G, Valet S, Platzer M, Hasse K, et al. 2002. Variant amino acids in the extracellular loops of murine and human vasopressin V2 receptors account for differences in cell surface expression and ligand affinity. Mol. Endocrinol. 16:799-813
84. Otaki JM, Firestein S. 2001. Length analyses of mammalian G-protein-coupled receptors. J. Theor. Biol. 211:77-100
85. Palczewski K, ed. 2000. Methods in Enzymology. Vol. 315: Vertebrate Phototransduction and the Visual Cycle. Part A. SanDiegeo, CA: Academic
86. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, et al. 2000. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289:739-45
87. Pebay-Peyroula E, Rummel G, Rosenbusch JP, Landau EM. 1997. X-ray structure of bacteriorhodopsin at 2.5 Å from microcrystals grown in lipidic cubic phases. Science 277:1676-81
88. Piserchio A, Prado GN, Zhang R, Yu J, Taylor L, et al. 2002. Structural insight into the role of the second intracellular loop of the bradykinin 2 receptor in signaling and internalization. Biopolymers 63:239-46
89. Pogozheva ID, Lomize AL, Mosberg HI. 1997. The transmembrane 7-alpha-bundle of rhodopsin: distance geometry calculations with hydrogen bonding constraints. Biophys. J. 72:1963-85
90. 2+-binding proteins in the retina. Trends Neurosci. 19:547-54
91. Ri Y, Ballesteros JA, Abrams CK, Oh S, Verselis VK, et al. 1999. The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophys. J. 76:2887-98
92. Riek RP, Rigoutsos I, Novotny J, Graham RM. 2001. Non-alpha-helical elements modulate polytopic membrane protein architecture. J. Mol. Biol. 306:349-62
93. Rosenbusch JP. 2001. Stability of membrane proteins: relevance for the selection of appropriate methods for high-resolution structure determinations. J. Struct. Biol. 136:144-57
94. Sakmar TP. 2002. Structure of rhodopsin and the superfamily of seven-helical receptors: the same and not the same. Curr. Opin. Cell Biol. 14:189-95
95. Sakmar TP, Menon ST, Marin EP, Awad ES. 2002. Rhodopsin: insights from recent structural studies. Annu. Rev. Biophys. Biomol. Struct. 31:443-84
96. Sankararamakrishnan R, Vishveshwara S. 1992. Geometry of proline-containing alpha-helices in proteins. Int. J. Pept. Protein Res. 39:356-63
97. Schertler GFX, Villa C, Henderson R. 1993. Projection structure of rhodopsin. Nature 362:770-72
98. Schulz A, Bruns K, Henklein P, Krause G, Schubert M, et al. 2000. Requirement of specific intrahelical interactions for stabilizing the inactive conformation of glycoprotein hormone receptors. J. Biol. Chem. 275:37860-69
99. Shacham S, Topf M, Avisar N, Glaser F, Marantz Y, et al. 2001. Modeling the 3D structure of GPCRs from sequence. Med. Res. Rev. 21:472-83
100. Shapiro DA, Kristiansen K, Weiner DM, Kroeze WK, Roth BL. 2002. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem. 277:11441-49
101. Shi L, Simpson MM, Ballesteros JA, Jayitch JA. 2001. The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. Biochemistry 40:12339-48
102. Shichida Y, Imai H. 1998. Visual pigment: G-protein-coupled receptor for light signals. Cell. Mol. Life Sci. 54:1299-315
103. Shinozaki H, Fanelli F, Liu XB, Jaquette J, Nakamura K, Segaloff DL. 2001. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness. Mol. Endocrinol. 15:972-84
104. Singh D, Hudson BS, Middleton C, Birge RR. 2000. Conformation and orientation of the retinyl chromophore in rhodopsin: A critical evaluation of recent NMR data on the basis of theoretical calculations results in a minimum energy structure consistent with all experimental data. Biochemistry 40:4201-4
105. Spalding TA, Burstein ES. 2001. Constitutively active muscarinic receptors. Life Sci. 68:2511-16
106. Spooner PJR, Sharples JM, Verhoeven MA, Lugtenburg J, Glaubitz C, Watts A. 2002. Relative orientation between the β-ionone ring and the polyene chain for the chromophore of rhodopsin in native membranes. Biochemistry 41:7549-55
107. Stark H, Sippl W, Ligneau X, Arrang JM, Ganellin CR, et al. 2001. Different antagonist binding properties of human and rat histamine H-3 receptors. Bioorg. Med. Chem. Lett. 11:951-54
108. Stenkamp RE, Filipek S, Driessen CAGG, Teller DC, Palczewski K. 2002. Crystal structure of rhodopsin: a template for cone visual pigments and other G protein-coupled receptors. Biochim. Biophys. Acta Biomembr. 1565:168-82
109. Stitham J, Martin KA, Hwa J. 2002. The critical role of transmembrane prolines in human prostacyclin receptor activation. Mol. Pharmacol. 61:1202-10
110. Subramaniam S, Henderson R. 2000. Crystallographic analysis of protein conformational changes in the bacteriorhodopsin photocycle. Biochim. Biophys. Acta Bioenerg. 1460:157-65
111. Tan Q, Lou JH, Borhan B, Karnaukhova E, Berova N, Nakanishi K. 1997. Absolute sense of twist of the C12-C13 bond of the retinal chromophore in bovine rhodopsin based on exciton-coupled CD spectra of 11,12-dihydroretinal analogues. Angew. Chem. Int. Ed. 36:2089-93
112. Teller DC, Okada T, Behnke CA, Palczewski K, Stenkamp RE. 2001. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40:7761-72
113. Tokita K, Katsuno T, Hocart SJ, Coy DH, Llinares M, et al. 2001. Molecular basis for selectivity of high affinity peptide antagonists for the gastrin-releasing peptide receptor. J. Biol. Chem. 276:36652-63
114. Unger VM, Hargrave PA, Baldwin JM, Schertler GFX. 1997. Arrangement of rhodopsin transmembrane alpha-helices. Nature 389:203-6
115. Uveges AJ, Kowal D, Zhang YX, Spangler TB, Dunlop J, et al. 2002. The role of transmembrane helix 5 in agonist binding to the human H3 receptor. J. Pharmacol. Exp. Ther. 301:451-58
116. Vakser IA, Jiang SL. 2002. Strategies for modeling the interactions of transmembrane helices of G protein-coupled receptors by geometric complementarity using the GRAMM computer algorithm. Methods Enzymol. 343:313-28
117. Vaughan M. 1998. G protein-coupled receptors minireview series. J. Biol. Chem. 273:17297
118. Visiers I, Ballesteros JA, Weinstein H. 2002. Three-dimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol. 343:329-71
119. Visiers I, Braunheim BB, Weinstein H. 2000. Prokink: a protocol for numerical evaluation of helix distortions by proline. Protein Eng. 13:603-6
120. Ward SDC, Hamdan FF, Bloodworth LM, Wess J. 2002. Conformational changes that occur during M-3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy. J. Biol. Chem. 277:2247-57
121. Watson S, Arkinstall S. 1994. The G-Protein Linked Receptor Factsbook. New York: Academic
122. Waugh DJJ, Gaivin RJ, Zuscik MJ, Gonzalez-Cabrera P, Ross SA, et al. 2001. Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha(1)-adrenergic receptor antagonist binding - imidazoline agonists bind like antagonists. J. Biol. Chem. 276:25366-71
123. Woolfson DN, Williams DH. 1990. The influence of proline residues on alpha-helical structure. FEBS Lett. 277:185-88
124. Xu W, Li J, Chen CG, Huang P, Weinstein H, et al. 2001. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors. Biochemistry 40:8018-29
125. Yang Y, Fong TM, Dickinson CJ, Mao C, Li JY, et al. 2000. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 39:14900-11
126. Yeagle PL, Choi G, Albert AD. 2001. Studies on the structure of the G-protein-coupled receptor rhodopsin including the putative G-protein binding site in unactivated and activated forms. Biochemistry 40:11932-37